1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => OpenAccess
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    










































































































































    Reproducibility of Deep Gray Matter Atrophy Rate Measurement in a Large Multicenter Dataset | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      



          


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleAdult Brain

  
      
Open Access

  
      
Reproducibility of Deep Gray Matter Atrophy Rate Measurement in a Large Multicenter Dataset
  
    	
A. Meijerman, H. Amiri, M.D. Steenwijk, M.A. Jonker, R.A. van Schijndel, K.S. Cover and H. Vrenken for the Alzheimer's Disease Neuroimaging Initiative

  
    	
American Journal of Neuroradiology January 2018,  39 (1) 46-53; DOI: https://doi.org/10.3174/ajnr.A5459 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵
    1. 

    2. Burns  JM, 
    3. Morris  JC
    . Neuropathology of Alzheimer's disease, non-demented aging and MCI. In: Mild Cognitive Impairment and Early Alzheimer's Disease: Detection and Diagnosis. Hoboken: John Wiley & Sons; 2008:17–34
  2. 2.↵
    1. 

    2. Iqbal  K, 
    3. Liu  F, 
    4. Gong  CX, et al
    . Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 2009;118:53–69 doi:10.1007/s00401-009-0486-3 pmid:19184068
    CrossRefPubMedWeb of Science
  3. 3.↵
    1. 

    2. Overk  CR, 
    3. Masliah  E
    . Pathogenesis of synaptic degeneration in Alzheimer's disease and Lewy body disease. Biochem Pharmacol 2014;88:508–16 doi:10.1016/j.bcp.2014.01.015 pmid:24462903
    CrossRefPubMed
  4. 4.↵
    1. 

    2. Stelmashook  EV, 
    3. Isaev  NK, 
    4. Genrikhs  EE, et al
    . Role of zinc and copper ions in the pathogenetic mechanisms of Alzheimer's and Parkinson's diseases. Biochemistry (Mosc) 2014;79:391–96 doi:10.1134/S0006297914050022 pmid:24954589
    CrossRefPubMed
  5. 5.↵
    1. 

    2. Mufson  EJ, 
    3. Binder  L, 
    4. Counts  SE, et al
    . Mild cognitive impairment: pathology and mechanisms. Acta Neuropathol 2012;123:13–30 doi:10.1007/s00401-011-0884-1 pmid:22101321
    CrossRefPubMedWeb of Science
  6. 6.↵
    1. 

    2. Stephan  BC, 
    3. Hunter  S, 
    4. Harris  D, et al
    . The neuropathological profile of mild cognitive impairment (MCI): a systematic review. Mol Psychiatry 2012;17:1056–76 doi:10.1038/mp.2011.147 pmid:22143004
    CrossRefPubMedWeb of Science
  7. 7.↵
    1. 

    2. Maghzi  AH, 
    3. Revirajan  N, 
    4. Julian  LJ, et al
    . Magnetic resonance imaging correlates of clinical outcomes in early multiple sclerosis. Mult Scler Relat Disord 2014;3:720–27 doi:10.1016/j.msard.2014.07.003 pmid:25891551
    CrossRefPubMed
  8. 8.↵
    1. 

    2. Rudick  RA, 
    3. Fisher  E, 
    4. Lee  JC, et al
    . Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group. Neurology 1999;53:1698–704 doi:10.1212/WNL.53.8.1698 pmid:10563615
    Abstract/FREE Full Text
  9. 9.↵
    1. 

    2. Sluimer  JD, 
    3. van der Flier  WM, 
    4. Karas  GB, et al
    . Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients. Radiology 2008;248:590–98 doi:10.1148/radiol.2482070938 pmid:18574133
    CrossRefPubMedWeb of Science
  10. 10.↵
    1. 

    2. Vercellino  M, 
    3. Masera  S, 
    4. Lorenzatti  M, et al
    . Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J Neuropathol Exp Neurol 2009;68:489–502 doi:10.1097/NEN.0b013e3181a19a5a pmid:19525897
    CrossRefPubMed
  11. 11.↵
    1. 

    2. Jiji  S, 
    3. Smitha  KA, 
    4. Gupta  AK, et al
    . Segmentation and volumetric analysis of the caudate nucleus in Alzheimer's disease. Eur J Radiol 2013;82:1525–30 doi:10.1016/j.ejrad.2013.03.012 pmid:23664648
    CrossRefPubMed
  12. 12.↵
    1. 

    2. Leung  KK, 
    3. Bartlett  JW, 
    4. Barnes  J, et al
    . Cerebral atrophy in mild cognitive impairment and Alzheimer disease: rates and acceleration. Neurology 2013;80:648–54 doi:10.1212/WNL.0b013e318281ccd3 pmid:23303849
    Abstract/FREE Full Text
  13. 13.↵
    1. 

    2. Macfarlane  MD, 
    3. Looi  JC, 
    4. Walterfang  M, et al
    . Executive dysfunction correlates with caudate nucleus atrophy in patients with white matter changes on MRI: a subset of LADIS. Psychiatry Res 2013;214:16–23 doi:10.1016/j.pscychresns.2013.05.010 pmid:23916538
    CrossRefPubMed
  14. 14.↵
    1. 

    2. Miller  MI, 
    3. Younes  L, 
    4. Ratnanather  JT, et al
    . Amygdalar atrophy in symptomatic Alzheimer's disease based on diffeomorphometry: the BIOCARD cohort. Neurobiol Aging 2015;36 Suppl 1:S3–S10 doi:10.1016/j.neurobiolaging.2014.06.032 pmid:25444602
    CrossRefPubMed
  15. 15.↵
    1. 

    2. Skup  M, 
    3. Zhu  H, 
    4. Wang  Y, et al
    . Sex differences in grey matter atrophy patterns among AD and aMCI patients: results from ADNI. Neuroimage 2011;56:890–906 doi:10.1016/j.neuroimage.2011.02.060 pmid:21356315
    CrossRefPubMed
  16. 16.↵
    1. 

    2. Štěpán-Buksakowska  I, 
    3. Szabó  N, 
    4. Hořínek  D, et al
    . Cortical and subcortical atrophy in Alzheimer disease: parallel atrophy of thalamus and hippocampus. Alzheimer Dis Assoc Disord 2014;28:65–72 doi:10.1097/WAD.0b013e318299d3d6 pmid:23751371
    CrossRefPubMed
  17. 17.↵
    1. 

    2. Yi  HA, 
    3. Möller  C, 
    4. Dieleman  N, et al
    . Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease. J Neurol Neurosurg Psychiatry 2016;87:425–32 doi:10.1136/jnnp-2014-309105 pmid:25904810
    Abstract/FREE Full Text
  18. 18.↵
    1. 

    2. Batista  S, 
    3. Zivadinov  R, 
    4. Hoogs  M, et al
    . Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol 2012;259:139–46 doi:10.1007/s00415-011-6147-1 pmid:21720932
    CrossRefPubMedWeb of Science
  19. 19.↵
    1. 

    2. Ramasamy  DP, 
    3. Benedict  RH, 
    4. Cox  JL, et al
    . Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study. J Neurol Sci 2009;282:47–54 doi:10.1016/j.jns.2008.12.034 pmid:19201003
    CrossRefPubMedWeb of Science
  20. 20.↵
    1. 

    2. Shiee  N, 
    3. Bazin  PL, 
    4. Zackowski  KM, et al
    . Revisiting brain atrophy and its relationship to disability in multiple sclerosis. PLoS One 2012;7:e37049 doi:10.1371/journal.pone.0037049 pmid:22615886
    CrossRefPubMed
  21. 21.↵
    1. 

    2. Hanganu  A, 
    3. Bedetti  C, 
    4. Degroot  C, et al
    . Mild cognitive impairment is linked with faster rate of cortical thinning in patients with Parkinson's disease longitudinally. Brain 2014;137:1120–29 doi:10.1093/brain/awu036 pmid:24613932
    CrossRefPubMedWeb of Science
  22. 22.↵
    1. 

    2. Mak  E, 
    3. Bergsland  N, 
    4. Dwyer  MG, et al
    . Subcortical atrophy is associated with cognitive impairment in mild Parkinson disease: a combined investigation of volumetric changes, cortical thickness, and vertex-based shape analysis. AJNR Am J Neuroradiol 2014;35:2257–64 doi:10.3174/ajnr.A4055 pmid:25082821
    Abstract/FREE Full Text
  23. 23.↵
    1. 

    2. Nemmi  F, 
    3. Sabatini  U, 
    4. Rascol  O, et al
    . Parkinson's disease and local atrophy in subcortical nuclei: insight from shape analysis. Neurobiol Aging 2015;36:424–33 doi:10.1016/j.neurobiolaging.2014.07.010 pmid:25174648
    CrossRefPubMed
  24. 24.↵
    1. 

    2. Kishi  T, 
    3. Matsunaga  S, 
    4. Oya  K, et al
    . Protection against brain atrophy by anti-dementia medication in mild cognitive impairment and Alzheimer's disease: meta-analysis of longitudinal randomized placebo-controlled trials. Int J Neuropsychopharmacol 2015;18:pyv070 doi:10.1093/ijnp/pyv070 pmid:26091818
    CrossRefPubMed
  25. 25.↵
    1. 

    2. Patenaude  B, 
    3. Smith  SM, 
    4. Kennedy  DN, et al
    . A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage 2011;56:907–22 doi:10.1016/j.neuroimage.2011.02.046 pmid:21352927
    CrossRefPubMedWeb of Science
  26. 26.↵
    1. 

    2. Fischl  B, 
    3. Salat  DH, 
    4. Busa  E, et al
    . Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33:341–55 doi:10.1016/S0896-6273(02)00569-X pmid:11832223
    CrossRefPubMedWeb of Science
  27. 27.↵
    1. 

    2. Fischl  B, 
    3. van der Kouwe  A, 
    4. Destrieux  C, et al
    . Automatically parcellating the human cerebral cortex. Cereb Cortex 2004;14:11–22 doi:10.1093/cercor/bhg087 pmid:14654453
    CrossRefPubMedWeb of Science
  28. 28.↵
    1. 

    2. Reuter  M, 
    3. Rosas  HD, 
    4. Fischl  B
    . Highly accurate inverse consistent registration: a robust approach. Neuroimage 2010;53:1181–96 doi:10.1016/j.neuroimage.2010.07.020 pmid:20637289
    CrossRefPubMedWeb of Science
  29. 29.↵
    1. 

    2. Reuter  M, 
    3. Schmansky  NJ, 
    4. Rosas  HD, et al
    . Within-subject template estimation for unbiased longitudinal image analysis. Neuroimage 2012;61:1402–18 doi:10.1016/j.neuroimage.2012.02.084 pmid:22430496
    CrossRefPubMedWeb of Science
  30. 30.↵
    1. 

    2. Mueller  SG, 
    3. Weiner  MW, 
    4. Thal  LJ, et al
    . Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement 2005;1:55–66 doi:10.1016/j.jalz.2005.06.003 pmid:17476317
    CrossRefPubMed
  31. 31.↵
    1. 

    2. Cover  KS, 
    3. van Schijndel  RA, 
    4. van Dijk  BW, et al
    . Assessing the reproducibility of the SienaX and Siena brain atrophy measures using the ADNI back-to-back MP-RAGE MRI scans. Psychiatry Res 2011;193:182–90 doi:10.1016/j.pscychresns.2011.02.012 pmid:21764565
    CrossRefPubMed
  32. 32.↵
    1. 

    2. Jack  CR  Jr.., 
    3. Bernstein  MA, 
    4. Fox  NC, et al
    . The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 2008;27:685–91 doi:10.1002/jmri.21049 pmid:18302232
    CrossRefPubMedWeb of Science
  33. 33.↵
    1. 

    2. Carstensen  B, 
    3. Simpson  J, 
    4. Gurrin  LC
    . Statistical models for assessing agreement in method comparison studies with replicate measurements. Int J Biostat 2008;4:Article 16 doi:10.2202/1557-4679.1107
    CrossRef
  34. 34.↵
    1. 

    2. de Vet  HCW, 
    3. Terwee  CB, 
    4. Mokkink  LB, et al
    . Measurement in Medicine: A Practical Guide. New York: Cambridge University Press; 2011
  35. 35.↵
    1. 

    2. Mulder  ER, 
    3. de Jong  RA, 
    4. Knol  DL, et al
    . Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST. Neuroimage 2014;92:169–81 doi:10.1016/j.neuroimage.2014.01.058 pmid:24521851
    CrossRefPubMed
  36. 36.↵
    1. 

    2. Bland  JM, 
    3. Altman  DG
    . Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1:307–10 doi:10.1016/s0140-6736(86)90837-8 pmid:2868172
    CrossRefPubMedWeb of Science
  37. 37.↵
    1. 

    2. Euser  AM, 
    3. Dekker  FW, 
    4. le Cessie  S
    . A practical approach to Bland-Altman plots and variation coefficients for log transformed variables. J Clin Epidemiol 2008;61:978–82 doi:10.1016/j.jclinepi.2007.11.003 pmid:18468854
    CrossRefPubMed
  38. 38.↵
    1. 

    2. Terwee  CB, 
    3. Bot  SD, 
    4. de Boer  MR, et al
    . Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007;60:34–42 doi:10.1016/j.jclinepi.2006.03.012 pmid:17161752
    CrossRefPubMedWeb of Science
  39. 39.↵
    1. 

    2. Twisk  JWR
    . Applied Multilevel Analysis: A Practical Guide for Medical Researchers. New York: Cambridge University Press; 2006
  40. 40.↵
    1. 

    2. Twisk  JWR
    . Applied Longitudinal Data Analysis for Epidemiology. New York: Cambridge University Press; 2013
  41. 41.↵
    1. 

    2. Jovicich  J, 
    3. Czanner  S, 
    4. Han  X, et al
    . MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths. Neuroimage 2009;46:177–92 doi:10.1016/j.neuroimage.2009.02.010 pmid:19233293
    CrossRefPubMedWeb of Science
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Reproducibility of Deep Gray Matter Atrophy Rate Measurement in a Large Multicenter Dataset
  
    	
A. Meijerman, H. Amiri, M.D. Steenwijk, M.A. Jonker, R.A. van Schijndel, K.S. Cover, H. Vrenken

  
    	
 American Journal of Neuroradiology Jan 2018, 39 (1) 46-53; DOI: 10.3174/ajnr.A5459 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement